Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.
BPC 157 is a stable gastric pentadecapeptide recently implicated with a role in hemostasis. While NO is largely implicated in hemostatic mechanisms, in tail-amputation-models under heparin- and warfarin-administration, both the NO-synthase (NOS)-blocker, L-NAME (prothrombotic) and the NOS-substrate...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4405609?pdf=render |
| _version_ | 1818835943026589696 |
|---|---|
| author | Mirjana Stupnisek Antonio Kokot Domagoj Drmic Masa Hrelec Patrlj Anita Zenko Sever Danijela Kolenc Bozo Radic Jelena Suran Davor Bojic Aleksandar Vcev Sven Seiwerth Predrag Sikiric |
| author_facet | Mirjana Stupnisek Antonio Kokot Domagoj Drmic Masa Hrelec Patrlj Anita Zenko Sever Danijela Kolenc Bozo Radic Jelena Suran Davor Bojic Aleksandar Vcev Sven Seiwerth Predrag Sikiric |
| author_sort | Mirjana Stupnisek |
| collection | DOAJ |
| description | BPC 157 is a stable gastric pentadecapeptide recently implicated with a role in hemostasis. While NO is largely implicated in hemostatic mechanisms, in tail-amputation-models under heparin- and warfarin-administration, both the NO-synthase (NOS)-blocker, L-NAME (prothrombotic) and the NOS-substrate L-arginine (antithrombotic), were little investigated. Objective. To investigate the effect of L-NAME and L-arginine on hemostatic parameters, and to reveal the effects of BPC 157 on the L-NAME- and L-arginine-induced hemostatic actions under different pathological condition: tail amputation without or with anticoagulants, heparin or warfarin.Tail amputation, and/or i.v.-heparin (10 mg/kg), i.g.-warfarin (1.5 mg/kg/day for 3 days) were used in rats. Treatment includes BPC 157, L-NAME, L-arginine, per se and their combination.After (tail) amputation, with or without i.v.-heparin or i.g.-warfarin, BPC 157 (10 μg/kg, 10 ng/kg, i.p., i.v. (heparin), 10 μg/kg i.g. (warfarin)) always reduced bleeding time and/or haemorrhage and counteracted thrombocytopenia. As for L-NAME and/or L-arginine, we noted: L-arginine (100 mg/kg i.p.)-rats: more bleeding, less/no thrombocytopenia; L-NAME (5 mg/kg i.p.)-rats: less bleeding (amputation only), but present thrombocytopenia; L-NAME+L-arginine-rats also exhibited thrombocytopenia: L-NAME counteracted L-arginine-increased bleeding, L-arginine did not counteract L-NAME-thrombocytopenia. All animals receiving BPC 157 in addition (BPC 157 μg+L-NAME; BPC 157 μg+L-arginine, BPC 157 μg+L-NAME+L-arginine), exhibited decreased haemorrhage and markedly counteracted thrombocytopenia.L-NAME (thrombocytopenia), L-arginine (increased haemorrhage) counteraction and BPC 157 (decreased haemorrhage, counteracted thrombocytopenia) with rescue against two different anticoagulants, implicate a BPC 157 modulatory and balancing role with rescued NO-hemostatic mechanisms. |
| first_indexed | 2024-12-19T02:58:44Z |
| format | Article |
| id | doaj.art-2c7ab2603b784481b2ef101298d8a72f |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-19T02:58:44Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-2c7ab2603b784481b2ef101298d8a72f2022-12-21T20:38:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01104e012345410.1371/journal.pone.0123454Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.Mirjana StupnisekAntonio KokotDomagoj DrmicMasa Hrelec PatrljAnita Zenko SeverDanijela KolencBozo RadicJelena SuranDavor BojicAleksandar VcevSven SeiwerthPredrag SikiricBPC 157 is a stable gastric pentadecapeptide recently implicated with a role in hemostasis. While NO is largely implicated in hemostatic mechanisms, in tail-amputation-models under heparin- and warfarin-administration, both the NO-synthase (NOS)-blocker, L-NAME (prothrombotic) and the NOS-substrate L-arginine (antithrombotic), were little investigated. Objective. To investigate the effect of L-NAME and L-arginine on hemostatic parameters, and to reveal the effects of BPC 157 on the L-NAME- and L-arginine-induced hemostatic actions under different pathological condition: tail amputation without or with anticoagulants, heparin or warfarin.Tail amputation, and/or i.v.-heparin (10 mg/kg), i.g.-warfarin (1.5 mg/kg/day for 3 days) were used in rats. Treatment includes BPC 157, L-NAME, L-arginine, per se and their combination.After (tail) amputation, with or without i.v.-heparin or i.g.-warfarin, BPC 157 (10 μg/kg, 10 ng/kg, i.p., i.v. (heparin), 10 μg/kg i.g. (warfarin)) always reduced bleeding time and/or haemorrhage and counteracted thrombocytopenia. As for L-NAME and/or L-arginine, we noted: L-arginine (100 mg/kg i.p.)-rats: more bleeding, less/no thrombocytopenia; L-NAME (5 mg/kg i.p.)-rats: less bleeding (amputation only), but present thrombocytopenia; L-NAME+L-arginine-rats also exhibited thrombocytopenia: L-NAME counteracted L-arginine-increased bleeding, L-arginine did not counteract L-NAME-thrombocytopenia. All animals receiving BPC 157 in addition (BPC 157 μg+L-NAME; BPC 157 μg+L-arginine, BPC 157 μg+L-NAME+L-arginine), exhibited decreased haemorrhage and markedly counteracted thrombocytopenia.L-NAME (thrombocytopenia), L-arginine (increased haemorrhage) counteraction and BPC 157 (decreased haemorrhage, counteracted thrombocytopenia) with rescue against two different anticoagulants, implicate a BPC 157 modulatory and balancing role with rescued NO-hemostatic mechanisms.http://europepmc.org/articles/PMC4405609?pdf=render |
| spellingShingle | Mirjana Stupnisek Antonio Kokot Domagoj Drmic Masa Hrelec Patrlj Anita Zenko Sever Danijela Kolenc Bozo Radic Jelena Suran Davor Bojic Aleksandar Vcev Sven Seiwerth Predrag Sikiric Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine. PLoS ONE |
| title | Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine. |
| title_full | Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine. |
| title_fullStr | Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine. |
| title_full_unstemmed | Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine. |
| title_short | Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine. |
| title_sort | pentadecapeptide bpc 157 reduces bleeding and thrombocytopenia after amputation in rats treated with heparin warfarin l name and l arginine |
| url | http://europepmc.org/articles/PMC4405609?pdf=render |
| work_keys_str_mv | AT mirjanastupnisek pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT antoniokokot pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT domagojdrmic pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT masahrelecpatrlj pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT anitazenkosever pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT danijelakolenc pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT bozoradic pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT jelenasuran pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT davorbojic pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT aleksandarvcev pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT svenseiwerth pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine AT predragsikiric pentadecapeptidebpc157reducesbleedingandthrombocytopeniaafteramputationinratstreatedwithheparinwarfarinlnameandlarginine |